Top 10 Bioprocess Technology Market To Grow At A Healthy Rate During Forecast Period

By Author: Makarand Vaidya
Total Articles: 82
Comment this article

The global top 10 bioprocess technology market is expected to USD 71.03 Billion by 2021 from USD 39.30 Billion in 2016, at a CAGR of 12.4% between 2016 and 2021.

Growth in the biopharmaceutical industry, increase in R&D spending, rising demand for vaccine production, and technological advancements form important growth drivers for this market. On the other hand, stringent regulatory policies and high cost of instruments are restraining market growth for bioprocess technologies.

The report provides an overall understanding of the global top 10 bioprocess technology market. This report segments the market on the basis of type and region.

On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, cell line development, flow cytometry, single-use bioprocessing, biologics safety testing, virus filtration, tangential flow filtration, and pyrogen testing. In 2016, the cell culture segment is expected to account for the largest share of the global top 10 bioprocess technology market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=30722776

On ...
... the basis of region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The report maps each bioprocess technology in these geographic and regional segments.

Research Methodologies Followed:

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global top 10 bioprocess technology market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

Geographical Growth Scenario:

In 2016, North America accounted for the largest share of the global top 10 bioprocess technology market. Growth in this market can be attributed to the increase in demand of high quality biologics, rising spending on R&D by top players in this region. Similarly, Asia is estimated to grow at the highest CAGR during the forecast period. The growth of this market is fueled by overall growth in the biopharmaceutical industry, investments by key market players in Asia countries, increasing government support, developments in R&D infrastructure, increasing outsourcing to Asia countries, and growing expertise and academic excellence in Asia.

Key Players:

The prominent players in the top 10 bioprocess technology market include GE Healthcare (U.S.), Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc.(U.S.), Bio-Rad Laboratories (U.S.), and Charles River Laboratories (U.S.).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=30722776

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com